.jpeg)
Is Trastuzumab a targeted drug?
Trastuzumab (Trastuzumab) is a targeted prescription drug. It is a monoclonal antibody that blocks the growth and division of HER2-positive breast cancer cells by specifically binding to and inhibiting the function of human epidermal growth factor receptor 2 (HER2). This is a humanized IgG1 light chain monoclonal antibody in which the complementarity determining regions (CDRs) of a HER2-specific mouse monoclonal antibody are genetically engineered to link to the human antibody framework region. Trastuzumab has been approved by the U.S. Food and Drug Administration (FDA) for the treatment of HER2-overexpressing breast cancer in the adjuvant and metastatic settings.
[ 免责声明 ] 本页面内容来自公开渠道（如FDA官网、Drugs官网、原研药厂官网等），仅供持有医疗专业资质的人员用于医学药学研究参考，不构成任何治疗建议或药品推荐。所涉药品可能未在中国大陆获批上市，不适用于中国境内销售和使用。如需治疗，请咨询正规医疗机构。本站不提供药品销售或代购服务。
